2025 Market Access Forecast: Four Game-Changing Trends Reshaping Pharma
Four Pivotal Trends Revolutionizing Market Access Strategies
2025 Pharma Forecast – Trends to Watch
As the pharmaceutical landscape evolves, ensuring market access should remain a top priority for industry stakeholders. As we look ahead to a year of expected advancements, several key trends will shape the landscape for manufacturers and key players. Archbow Consulting has detailed four prevalent topics highlighting the industry’s movement toward digital transformation, cost management, treatment innovation, and value-based service delivery.
Pharmaceutical Executive teamed with Archbow Consulting to help market access teams start thinking about how they can tell their story in the year ahead. These four trends detail why evolved preparation, thought, and engagement will be needed to meet transformative changes in 2025. We hope this list gives you the added insight to help you maximize your opportunities over the next year.
How did we do on this list? Is there anything else you would have included? Let us know – we’d love to hear from you.
For additional insights on this topic, you may also enjoy the following:
Is Your Specialty Distribution Fee Schedule Keeping Pace?
Specialty distribution fee schedules must evolve with market conditions and service requirements. Archbow provides benchmarking, FMV analysis, and negotiation support to help manufacturers establish informed, defensible agreements.
Brand Planning Season is Here: Is Patient Access Strategy at the Table?
Build patient access into 2027 brand planning to reduce therapy delays, strengthen launch readiness, and drive sustainable pharmaceutical brand growth.
Thinking Beyond the One-Size-Fits-All Approach: Choosing the Ideal 3PL Partnership
Today’s 3PL landscape offers more specialized distribution solutions than ever before. Learn how manufacturers can evaluate third-party logistics providers, align capabilities to product needs, and make informed 3PL partner decisions for a successful pharmaceutical product launch.
SUBSCRIBE
Subscribe to receive news and updates from Archbow Consulting
|
|